Cargando…
Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
BACKGROUND: Combinations of adjuvant sensitizers with anticancer drugs is a promising new strategy to reverse chemoresistance. Ursolic acid (UA) is one of the natural pentacyclic triterpene compounds known to have many pharmacological characteristics such as anti-inflammatory and anticancer properti...
Autores principales: | Wu, Shouhai, Zhang, Tianpeng, Du, Jingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087784/ https://www.ncbi.nlm.nih.gov/pubmed/27822011 http://dx.doi.org/10.2147/DDDT.S110505 |
Ejemplares similares
-
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021) -
VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014) -
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022) -
Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity
por: Xu, Haozhe, et al.
Publicado: (2023) -
Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions
por: Babaei, Faezeh, et al.
Publicado: (2019)